Book contents
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Copyright page
- Epigraph
- Contents
- Contributors
- Section I General Hematology and Hematopathology
- Section II Non-Neoplastic Hematologic Disorders of Blood and Bone Marrow
- Chapter 3 Anemia
- Chapter 4 Bone Marrow Failure Syndromes
- Chapter 5 Inherited Leukocyte Disorders
- Chapter 6 Other Conditions
- Section III Non-Neoplastic Disorders of Extramedullary Lymphoid Tissues
- Section IV Neoplastic Disorders of Bone Marrow
- Section V Mature Lymphoid Neoplasms
- Section VI Histiocytic Disorders and Neoplasms
- Index
- References
Chapter 5 - Inherited Leukocyte Disorders
from Section II - Non-Neoplastic Hematologic Disorders of Blood and Bone Marrow
Published online by Cambridge University Press: 25 January 2024
Book contents
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Pediatric Pathology of Hematopoietic and Histiocytic Disorders
- Copyright page
- Epigraph
- Contents
- Contributors
- Section I General Hematology and Hematopathology
- Section II Non-Neoplastic Hematologic Disorders of Blood and Bone Marrow
- Chapter 3 Anemia
- Chapter 4 Bone Marrow Failure Syndromes
- Chapter 5 Inherited Leukocyte Disorders
- Chapter 6 Other Conditions
- Section III Non-Neoplastic Disorders of Extramedullary Lymphoid Tissues
- Section IV Neoplastic Disorders of Bone Marrow
- Section V Mature Lymphoid Neoplasms
- Section VI Histiocytic Disorders and Neoplasms
- Index
- References
Summary
Table 5.1 provides an overview of the inherited leukocyte disorders covered in this chapter.
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2024
References
Hoffmann, K, Dreger, CK, Olins, AL, et al. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly). Nat Genet. 2002;31(4):410–4. doi: 10.1038/ng925Google Scholar
Borovik, L, Modaff, P, Waterham, HR, et al. Pelger-Huet anomaly and a mild skeletal phenotype secondary to mutations in LBR. Am J Med Genet A. 2013;161A(8):2066–73. doi: 10.1002/ajmg.a.36019Google Scholar
Chitayat, D, Gruber, H, Mullen, BJ, et al. Hydrops-ectopic calcification-moth-eaten skeletal dysplasia (Greenberg dysplasia): prenatal diagnosis and further delineation of a rare genetic disorder. Am J Med Genet. 1993;47(2):272–7. doi: 10.1002/ajmg.1320470226Google Scholar
Oosterwijk, JC, Mansour, S, van Noort, G, et al. Congenital abnormalities reported in Pelger-Huët homozygosity as compared to Greenberg/HEM dysplasia: highly variable expression of allelic phenotypes. J Med Genet. 2003;40(12):937–41. doi: 10.1136/jmg.40.12.937Google Scholar
Waterham, HR, Koster, J, Mooyer, P, et al. Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene. Am J Hum Genet. 2003;72(4):1013–7. doi: 10.1086/373938Google Scholar
Swerdlow, S, Campo, E, Harris, N, et al., eds. WHO classification of tumors of haematopoietic and lymphoid tissues. Rev. 4th ed. IARC Press; 2017.Google Scholar
Wang, E, Boswell, E, Siddiqi, I, et al. Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly. Am J Clin Pathol. 2011;135(2):291–303. doi: 10.1309/AJCPVFY95MAOBKRSGoogle Scholar
Kennedy, GA, Kay, TD, Johnson, DW, et al. Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases. Pathology. 2002;34(3):263–6. doi: 10.1080/0031302022013136Google Scholar
Gondo, H, Okamura, C, Osaki, K, et al. Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;26(11):1255–7. doi: 10.1038/sj.bmt.1702682Google Scholar
van Hook, L, Spivack, C, Duncanson, FP. Acquired Pelger-Huet anomaly associated with Mycoplasma pneumoniae pneumonia. Am J Clin Pathol. 1985;84(2):248–51. doi: 10.1093/ajcp/84.2.248Google Scholar
Cicchitto, G, Parravicini, M, De Lorenzo, S, et al. Tuberculosis and Pelger-Huët anomaly. Case report. Panminerva Med. 1999;41(4):367–9.Google Scholar
Seri, M, Cusano, R, Gangarossa, S, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet. 2000;26(1):103–5. doi: 10.1038/79063Google Scholar
Kelley, MJ, Jawien, W, Ortel, TL, et al. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet. 2000;26(1):106–8. doi: 10.1038/79069Google Scholar
Noris, P, Spedini, P, Belletti, S, et al. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med. 1998;104(4):355–60. doi: 10.1016/s0002-9343(98)00062-xGoogle Scholar
Rodriguez, V, Nichols, WL, Charlesworth, JE, et al. Sebastian platelet syndrome: a hereditary macrothrombocytopenia. Mayo Clin Proc. 2003;78(11):1416–21. doi: 10.4065/78.11.1416Google Scholar
Peterson, LC, Rao, KV, Crosson, JT, et al. Fechtner syndrome – a variant of Alport‘s syndrome with leukocyte inclusions and macrothrombocytopenia. Blood. 1985;65(2):397–406.Google Scholar
Heath, KE, Campos-Barros, A, Toren, A, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet. 2001;69(5):1033–45. doi: 10.1086/324267Google Scholar
Kunishima, S, Saito, H. Advances in the understanding of MYH9 disorders. Curr Opin Hematol. 2010;17(5):405–10. doi: 10.1097/MOH.0b013e32833c069cGoogle Scholar
Hsia, CC, Xenocostas, A. May-Hegglin anomaly. Blood. 2012;119(2):328. doi: 10.1182/blood-2010-12-325431Google Scholar
Sadaf, A, Ware, RE. Microscope diagnosis of MYH9-related thrombocytopenia. Blood. 2021;138(11):1000. doi: 10.1182/blood.2021012044Google Scholar
Siddiqui, T. Ultrastructure of the May-Hegglin anomaly. J Pak Med Assoc. 1997;47(9):224–6.Google Scholar
Okita, JR, Frojmovic, MM, Kristopeit, S, et al. Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain). Blood. 1989;74(2):715–21.Google Scholar
Chediak, MM. [New leukocyte anomaly of constitutional and familial character]. Rev Hematol. 1952;7(3):362–7.Google Scholar
Higashi, O. Congenital gigantism of peroxidase granules; the first case ever reported of qualitative abnormity of peroxidase. Tohoku J Exp Med. 1954;59(3):315–32. doi: 10.1620/tjem.59.315Google Scholar
Nagai, K, Ochi, F, Terui, K, et al. Clinical characteristics and outcomes of Chédiak-Higashi syndrome: a nationwide survey of Japan. Pediatr Blood Cancer. 2013;60(10):1582–6. doi: 10.1002/pbc.24637Google Scholar
Tchernev, VT, Mansfield, TA, Giot, L, et al. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med. 2002;8(1):56–64.Google Scholar
Antunes, H, Pereira, A, Cunha, I. Chediak-Higashi syndrome: pathognomonic feature. Lancet. 2013;382(9903):1514. doi: 10.1016/S0140-6736(13)60020-3Google Scholar
Lozano, ML, Rivera, J, Sánchez-Guiu, I, et al. Towards the targeted management of Chediak-Higashi syndrome. Orphanet J Rare Dis. 2014;9:132. doi: 10.1186/s13023-014-0132-6Google Scholar
Do, L, Pasalic, L. Lymphocytes in Sanfilippo syndrome display characteristic Alder-Reilly anomaly. Blood. 2019;134(14):1194. doi: 10.1182/blood.2019002412Google Scholar